FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Janet Rasey

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Tomography, Emission-Computed

Physiology

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
J Scott Brockenbrough; Qinghua Feng; John Grierson; Stephen E Hawes; Antoine Leblond; Janice K Morihara; Janet S Rasey; Timothee Souquet; Joshua E Stern; Linda W Wiens; Hubert Vesselle
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.
Alexander Salskov; Stephen E Hawes; Joshua E Stern; Qinghua Feng; C Diana Jordan; Linda W Wiens; Janet S Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle
Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung.
Stephen E Hawes; Joshua E Stern; Qinghua Feng; Linda W Wiens; Janet S Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle
DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Janet Rasey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: J Scott Brockenbrough; Qinghua Feng; John Grierson; Stephen E Hawes; Antoine Leblond; Janice K Morihara; Janet S Rasey; Timothee Souquet; Joshua E Stern; Linda W Wiens; Hubert Vesselle
Tumor 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of (18)F-FLT PET studies in lung tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1181-8.
2011: Alexander Salskov; Stephen E Hawes; Joshua E Stern; Qinghua Feng; C Diana Jordan; Linda W Wiens; Janet S Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle
Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung.
Journal of oncology 2011;2011():950140.
2010: Stephen E Hawes; Joshua E Stern; Qinghua Feng; Linda W Wiens; Janet S Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle
DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.
Lung cancer (Amsterdam, Netherlands) 2010;69(2):172-9.
2010: John R Grierson; J Scott Brockenbrough; Janet S Rasey; Linda W Wiens; Hubert Vesselle
Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).
Nucleosides, nucleotides & nucleic acids 2010;29(1):49-54.
2009: J Scott Brockenbrough; Janice K Morihara; Stephen E Hawes; Joshua E Stern; Janet S Rasey; Linda W Wiens; Qinghua Feng; Hubert Vesselle
Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2009;57(11):1087-97.
2007: J Scott Brockenbrough; Janet S Rasey; John R Grierson; Linda W Wiens; Hubert Vesselle
A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.
Nuclear medicine and biology 2007;34(6):619-23.
2007: John R Grierson; J Scott Brockenbrough; Janet S Rasey; Linda W Wiens; Jeffrey L Schwartz; Robert Jordan; Hubert Vesselle
Evaluation of 5'-deoxy-5'-[F-18]fluorothymidine as a tracer of intracellular thymidine phosphorylase activity.
Nuclear medicine and biology 2007;34(5):471-8.
2003: Joseph G Rajendran; D C Wilson; Ernest U Conrad; Lanell M Peterson; James D Bruckner; Janet S Rasey; LK Chin; PD Hofstrand; John R Grierson; Janet F Eary; Kenneth A Krohn
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.
European journal of nuclear medicine and molecular imaging 2003;30(5):695-704.
2002: Janet S Rasey; John R Grierson; Linda W Wiens; Pamella D Kolb; Jeffrey L Schwartz
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(9):1210-7.
2000: Oliver W Press; Janet S Rasey
Principles of radioimmunotherapy for hematologists and oncologists.
Seminars in oncology 2000;27(6 Suppl 12):62-73.
2000: Jeffrey L Schwartz; Robert Jordan; William K Kaufmann; Janet S Rasey; Kenneth J Russell; R R Weichselbaum
Evidence for the expression of radiation-induced potentially lethal damage being a p53-dependent process.
International journal of radiation biology 2000;76(8):1037-43.
2000: Janet S Rasey; J J Casciari; PD Hofstrand; Mark Muzi; Michael M Graham; LK Chin
Determining hypoxic fraction in a rat glioma by uptake of radiolabeled fluoromisonidazole.
Radiation research 2000;153(1):84-92.
1999: Janet S Rasey
The art of grant writing.
Current biology : CB 1999;9(11):R387.
1999: Janet S Rasey; PD Hofstrand; LK Chin; TJ Tewson
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(6):1072-9.
1999: Jeffrey L Schwartz; Janet S Rasey; Linda W Wiens; Robert Jordan; Kenneth J Russell
Functional inactivation of p53 by HPV-E6 transformation is associated with a reduced expression of radiation-induced potentially lethal damage.
International journal of radiation biology 1999;75(3):285-91.
1998: L A Young; Ira J Kalet; Janet S Rasey; J A Nelson
125I brachytherapy k-edge dose enhancement with AgTPPS4.
Medical physics 1998;25(5):709-18.
1997: Michael M Graham; Lanell M Peterson; Jeanne M Link; M L Evans; Janet S Rasey; W J Koh; James H Caldwell; Kenneth A Krohn
Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1631-6.
1996: Wui-Jin Koh; Marc R Mayberg; J Chambers; KL Lindsley; A Tran; Janet S Rasey; TW Griffin
The potential role of external beam radiation in preventing restenosis after coronary angioplasty.
International journal of radiation oncology, biology, physics 1996;36(4):829-34.
1996: C M Gajdusek; H Tian; S London; D Zhou; Janet S Rasey; Marc R Mayberg
Gamma radiation effect on vascular smooth muscle cells in culture.
International journal of radiation oncology, biology, physics 1996;36(4):821-8.
1996: Janet S Rasey; Wui-Jin Koh; M L Evans; Lanell M Peterson; Thomas K Lewellen; Michael M Graham; Kenneth A Krohn
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.
International journal of radiation oncology, biology, physics 1996;36(2):417-28.
1995: Wui-Jin Koh; K S Bergman; Janet S Rasey; Lanell M Peterson; M L Evans; Michael M Graham; John R Grierson; KL Lindsley; Thomas K Lewellen; Kenneth A Krohn
Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.
International journal of radiation oncology, biology, physics 1995;33(2):391-8.
1995: J J Casciari; L K Chin; John Livesey; D Boyles; R. Grant Steen; Janet S Rasey
Growth rate, labeling index, and radiation survival of cells grown in the Matrigel thread in vitro tumor model.
In vitro cellular & developmental biology. Animal 1995;31(8):582-9.
1995: James H Caldwell; J R Revenaugh; G V Martin; P M Johnson; Janet S Rasey; Kenneth A Krohn
Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1633-8.
1995: J J Casciari; Michael M Graham; Janet S Rasey
A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data.
Medical physics 1995;22(7):1127-39.
1995: Alexander M Spence; Janet S Rasey; L Dwyer-Hansen; Z Grunbaum; J Livesey; L Chin; N Nelson; D Stein; Kenneth A Krohn; F Ali-Osman
Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: comparison with prior results with phosphorothioates.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;35(3):216-26.
1995: Marc R Mayberg; Z Luo; S London; C Gajdusek; Janet S Rasey
Radiation inhibition of intimal hyperplasia after arterial injury.
Radiation research 1995;142(2):212-20.
1995: J J Casciari; Janet S Rasey
Determination of the radiobiologically hypoxic fraction in multicellular spheroids from data on the uptake of [3H]fluoromisonidazole.
Radiation research 1995;141(1):28-36.
1994: Thomas Buchholz; Janet S Rasey; George E Laramore; John Livesey; L Chin; Ruedi Risler; Donald K Hamlin; Alexander M Spence; TW Griffin
Concomitant boron-neutron capture therapy during fast-neutron irradiation of a rat glioma.
Radiology 1994;191(3):863-7.
1994: Wui-Jin Koh; TW Griffin; Janet S Rasey; George E Laramore
Positron emission tomography. A new tool for characterization of malignant disease and selection of therapy.
Acta oncologica (Stockholm, Sweden) 1994;33(3):323-7.
1993: G V Martin; J E Biskupiak; James H Caldwell; Janet S Rasey; Kenneth A Krohn
Characterization of iodovinylmisonidazole as a marker for myocardial hypoxia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(6):918-24.
1992: G V Martin; James H Caldwell; Michael M Graham; John R Grierson; K Kroll; M J Cowan; Thomas K Lewellen; Janet S Rasey; J J Casciari; Kenneth A Krohn
Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(12):2202-8.
1992: Wui-Jin Koh; Janet S Rasey; M L Evans; John R Grierson; Thomas K Lewellen; Michael M Graham; Kenneth A Krohn; TW Griffin
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.
International journal of radiation oncology, biology, physics 1992;22(1):199-212.
1991: C C Badger; Janet S Rasey; C Nourigat; D R Fisher; T E Hui; Z M Wu; Irwin D Bernstein
WR2721 protection of bone marrow in 131I-labeled antibody therapy.
Radiation research 1991;128(3):320-4.
1991: J L Prekeges; Janet S Rasey; Z Grunbaum; K H Krohn
Reduction of fluoromisonidazole, a new imaging agent for hypoxia.
Biochemical pharmacology 1991;42(12):2387-95.
1991: J E Biskupiak; John R Grierson; Janet S Rasey; G V Martin; Kenneth A Krohn
Synthesis of an (iodovinyl)misonidazole derivative for hypoxia imaging.
Journal of medicinal chemistry 1991;34(7):2165-8.
1990: Michael M Graham; M L Evans; D D Dahlen; P A Mahler; Janet S Rasey
Pharmacological alteration of the lung vascular response to radiation.
International journal of radiation oncology, biology, physics 1990;19(2):329-39.
1990: G V Martin; M D Cerqueira; James H Caldwell; Janet S Rasey; L Embree; Kenneth A Krohn
Fluoromisonidazole. A metabolic marker of myocyte hypoxia.
Circulation research 1990;67(1):240-4.
1990: Janet S Rasey; N J Nelson; L Chin; M L Evans; Z Grunbaum
Characteristics of the binding of labeled fluoromisonidazole in cells in vitro.
Radiation research 1990;122(3):301-8.
1990: Janet S Rasey; S Magee; N Nelson; L Chin; Kenneth A Krohn
Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;17(2):167-73.
1990: Z Grunbaum; K Kroll; J L Greene; Janet S Rasey; Kenneth A Krohn
Synthesis and radiobiological applications of [35S]L-homocysteine thiolactone.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(5):473-8.
1989: Janet S Rasey; Wui-Jin Koh; John R Grierson; Z Grunbaum; Kenneth A Krohn
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
International journal of radiation oncology, biology, physics 1989;17(5):985-91.
1989: John R Grierson; Jeanne M Link; C A Mathis; Janet S Rasey; Kenneth A Krohn
A radiosynthesis of fluorine-18 fluoromisonidazole.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(3):343-50.
1989: G V Martin; James H Caldwell; Janet S Rasey; Z Grunbaum; M Cerqueira; Kenneth A Krohn
Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(2):194-201.
1988: Alexander M Spence; Kenneth A Krohn; J E Steele; S E Edmondson; Janet S Rasey
WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cord.
Pharmacology & therapeutics 1988;39(1-3):89-91.
1988: Janet S Rasey; Alexander M Spence; C C Badger; Kenneth A Krohn; D M Vera; John Livesey
Specific protection of different normal tissues.
Pharmacology & therapeutics 1988;39(1-3):33-43.
1988: John Livesey; Janet S Rasey; S Vertrees; L M Freeman; S Magee; N J Nelson; L Chin; Z Grunbaum; Kenneth A Krohn
In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
Pharmacology & therapeutics 1988;39(1-3):215-7.
1987: Janet S Rasey; Z Grunbaum; S Magee; N J Nelson; P L Olive; R E Durand; Kenneth A Krohn
Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
Radiation research 1987;111(2):292-304.
1987: M L Evans; Michael M Graham; P A Mahler; Janet S Rasey
Use of steroids to suppress vascular response to radiation.
International journal of radiation oncology, biology, physics 1987;13(4):563-7.
1987: P A Mahler; Janet S Rasey; M B Yatvin
Influence of protein nutrition on dose-survival relationship following rat kidney irradiation.
Radiation research 1987;109(2):238-44.
1987: Z Grunbaum; S J Freauff; Kenneth A Krohn; D S Wilbur; S Magee; Janet S Rasey
Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(1):68-75.
1986: Janet S Rasey; Kenneth A Krohn; S Magee; N Nelson; L Chin
Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
Radiation research 1986;108(2):167-75.
1986: Alexander M Spence; S W Edmondson; Kenneth A Krohn; Z Grunbaum; Janet S Rasey; J E Steele
Toxicity and biodistribution of the radioprotectors, WR2721, WR77913, and WR3689, in the CNS following intraventricular or intracisternal administration.
International journal of radiation oncology, biology, physics 1986;12(9):1653-60.
1986: M L Evans; Michael M Graham; P A Mahler; Janet S Rasey
Changes in vascular permeability following thorax irradiation in the rat.
Radiation research 1986;107(2):262-71.
1986: Janet S Rasey; Kenneth A Krohn; T W Menard; Alexander M Spence
Comparative biodistribution and radioprotection studies with three radioprotective drugs in mouse tumors.
International journal of radiation oncology, biology, physics 1986;12(8):1487-90.
1986: Alexander M Spence; Kenneth A Krohn; S W Edmondson; J E Steele; Janet S Rasey
Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection.
International journal of radiation oncology, biology, physics 1986;12(8):1479-82.
1986: Janet S Rasey; Kenneth A Krohn; Z Grunbaum; Alexander M Spence; T W Menard; R A Wade
Synthesis, biodistribution, and autoradiography of radiolabeled S-2-(3-methylaminopropylamino)ethylphosphorothioic acid (WR-3689).
Radiation research 1986;106(3):366-79.
1985: Janet S Rasey; Kenneth A Krohn; Z Grunbaum; P J Conroy; K Bauer; R M Sutherland
Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
Radiation research 1985;102(1):76-85.
1985: Janet S Rasey; Z Grunbaum; Kenneth A Krohn; T W Menard; Alexander M Spence
Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913).
Radiation research 1985;102(1):130-7.
1985: Janet S Rasey; Z Grunbaum; K Krohn; N Nelson; L Chin
Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
Radiation research 1985;101(3):473-9.
1984: K W Anderson; Kenneth A Krohn; Z Grunbaum; R B Phillips; P A Mahler; T W Menard; Alexander M Spence; Janet S Rasey
Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids.
International journal of radiation oncology, biology, physics 1984;10(9):1511-5.
1981: Steven M Larson; P L Weiden; Z Grunbaum; henry kaplan; Janet S Rasey; Michael M Graham; G E Sale; G D Harp; D L Williams
Positron imaging feasibility studies. II: Characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(10):875-9.
1981: Steven M Larson; P L Weiden; Z Grunbaum; Janet S Rasey; henry kaplan; Michael M Graham; G D Harp; G E Sale; D L Williams
Positron imaging feasibility studies. I: Characteristics of [3H]thymidine uptake in rodent and canine neoplasms: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(10):869-74.
1981: Steven M Larson; Z Grunbaum; Janet S Rasey
The role of transferrins in gallium uptake.
International journal of nuclear medicine and biology 1981;8(4):257-66.
1980: Steven M Larson; Z Grunbaum; Janet S Rasey
Positron imaging feasibility studies: selective tumor concentration of 3H-thymidine, 3H-uridine, and 14C-2-deoxyglucose.
Radiology 1980;134(3):771-3.
1980: Steven M Larson; Janet S Rasey; D R Allen; N J Nelson; Z Grunbaum; G D Harp; D L Williams
Common pathway for tumor cell uptake of gallium-67 and iron-59 via a transferrin receptor.
Journal of the National Cancer Institute 1980;64(1):41-53.